acquisition of Memo Therapeutics

PARIS: Ipsen (Euronext: IPN; ADR: IPSEY) and Memo Therapeutics AG announced today they have entered into a definitive share purchase agreement.  Under the terms, Ipsen will acquire all outstanding shares of Memo Therapeutics, with a primary focus on advancing the Phase II…